Investor Relations
The investor pages that follow are your resource for financial information about Achillion Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
May 15, 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
May 9, 2013
Achillion to Present at Three Upcoming Investor Conferences
View all »Events & Presentations
May 30, 2013 at 2:10 PM ET
Deutsche Bank 38th Annual Health Care Conference
|